Startseite>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Azaguanine-8

Azaguanine-8

Katalog-Nr.GC11843

Azaguanin-8 ist ein Purin-Analogon, das antineoplastische AktivitÄt zeigt. Azaguanin-8 wirkt als Antimetabolit und baut sich leicht in RibonukleinsÄuren ein, stÖrt normale Biosynthesewege und hemmt so das Zellwachstum.

Products are for research use only. Not for human use. We do not sell to patients.

Azaguanine-8 Chemische Struktur

Cas No.: 134-58-7

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
41,00 $
Auf Lager
50mg
47,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

8-Azaguanine is a purine analogue which shows antineoplastic activity.

8-Azaguanine is a purine analogue which shows antineoplastic activity. The results show that cell viability decreases after incubation with 8-Azaguanine, in a dose and time dependent manner. After 24 h of treatment with 8-Azaguanine the IC50 for CEM cell line is about 100 μM while for MOLT3 cell line the IC50 is about 10 μM. CEM and MOLT3 cells surface expression of CD26 increases after treatment with 8-Azaguanine in a concentrations dependent manner[1].

References:
[1]. Dourado M, et al. CD26/DPPIV expression and 8-azaguanine response in T-acute lymphoblastic leukaemia cell lines in culture. Pathophysiology. 2007 May;14(1):3-10.

Bewertungen

Review for Azaguanine-8

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Azaguanine-8

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.